Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate
- PMID: 9741911
- DOI: 10.1016/s0168-3659(97)00235-6
Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate
Abstract
Recognition, internalization, and subcellular trafficking of N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer conjugates containing N-acylated galactosamine (GalN) or monoclonal OV-TL16 antibodies (Ab) have been investigated in human hepatocarcinoma HepG2 and ovarian carcinoma OVCAR-3 cells, respectively. The intrinsic fluorescence of fluorescein or adriamycin (ADR) attached to HPMA copolymers permitted us to follow the subcellular fate of HPMA copolymer conjugates by confocal fluorescence microscopy and fluorescence spectroscopy. The pattern of fluorescence during incubation of HPMA copolymer-ADR-GalN conjugate containing lysosomally degradable tetrapeptide (GFLG) side-chains with HepG2 cells was consistent with conjugate recognition, internalization, localization in lysosomes, followed by the release of ADR from the polymer chains and ultimately diffusion via the cytoplasm into the cell nuclei. A similar pattern was observed in OVCAR-3 cells for Ab targeted HPMA copolymer conjugates. To test our hypothesis that HPMA-copolymer-bound anticancer drugs will be inaccessible to the energy-driven P-glycoprotein efflux pump in multidrug resistant (MDR) cells, we have compared the internalization of the HPMA copolymer-ADR conjugates by sensitive (A2780) and ADR-resistant (A2780/AD) ovarian carcinoma cell lines. Preliminary data on relative retention of ADR in MDR (A2780/AD) cells indicate a higher intracellular ADR concentration after incubation with HPMA copolymer-ADR conjugate when compared to incubation with free (unbound) ADR.
Similar articles
-
HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro.Int J Cancer. 1998 Feb 9;75(4):600-8. doi: 10.1002/(sici)1097-0215(19980209)75:4<600::aid-ijc18>3.0.co;2-c. Int J Cancer. 1998. PMID: 9466663
-
HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line.Eur J Pharm Biopharm. 2000 Jan;49(1):11-5. doi: 10.1016/s0939-6411(99)00033-8. Eur J Pharm Biopharm. 2000. PMID: 10613922
-
HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line.J Control Release. 1998 Jul 31;54(2):223-33. doi: 10.1016/s0168-3659(98)00009-1. J Control Release. 1998. PMID: 9724909
-
Cytoplasmic delivery and nuclear targeting of synthetic macromolecules.J Control Release. 2003 Feb 21;87(1-3):89-105. doi: 10.1016/s0168-3659(02)00352-8. J Control Release. 2003. PMID: 12618026 Review.
-
Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers.Curr Pharm Biotechnol. 2003 Oct;4(5):311-22. doi: 10.2174/1389201033489711. Curr Pharm Biotechnol. 2003. PMID: 14529421 Review.
Cited by
-
Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review.Nano Today. 2013 Jun 1;8(3):313-331. doi: 10.1016/j.nantod.2013.04.006. Nano Today. 2013. PMID: 23888183 Free PMC article.
-
Cell surface self-assembly of hybrid nanoconjugates via oligonucleotide hybridization induces apoptosis.ACS Nano. 2014 Jan 28;8(1):719-30. doi: 10.1021/nn4053827. Epub 2013 Dec 10. ACS Nano. 2014. PMID: 24308267 Free PMC article.
-
Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells.Mol Pharm. 2008 Sep-Oct;5(5):696-709. doi: 10.1021/mp800006e. Epub 2008 Aug 27. Mol Pharm. 2008. PMID: 18729468 Free PMC article.
-
HPMA copolymer-bound doxorubicin induces apoptosis in ovarian carcinoma cells by the disruption of mitochondrial function.Mol Pharm. 2006 May-Jun;3(3):351-61. doi: 10.1021/mp050065e. Mol Pharm. 2006. PMID: 16749867 Free PMC article.
-
Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells.J Control Release. 2007 Dec 4;124(1-2):6-10. doi: 10.1016/j.jconrel.2007.08.016. Epub 2007 Aug 23. J Control Release. 2007. PMID: 17869367 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials